StockTipsArenaBeta

SELL Dr. Reddy's Laboratories Limited — Gaurav Sharma, Globe Capital Market

SELLDr. Reddy's Laboratories Limited
Dr. Reddy's Laboratories share price target & all analyst calls

byGaurav Sharma, Globe Capital MarketHorizon: Swing (≤2wk)9 Oct 2026via NDTV Profit (Live)

Entry₹1,180Inferred
Target₹1,120
Total upside +5.08% (call closed)
Stop loss₹1,200-1.69% risk
Exit₹1,200Stop-loss hit — time not yet verified
Stop-loss hit-1.69%
Follow Gaurav Sharma for new calls(26% target hit, 92 closed calls)Get alertsWatch DRREDDY for new buy/sell callsGet alertsSee 1 active Swing call on DRREDDYSee 219 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this SELL call — facts from public sources, machine-classified. Not investment advice.

As of 9 Oct, 3:30 pm IST
1 supporting1 neutral6 opposing
Supports the SELL call (1)

1 other SEBI-registered advisor has an active swing SELL call on this stock, issued in the last 14 days

Advisor consensus · same horizon·8 Oct · yesterday

Neutral / worth noting (1)

Q2 FY27 results scheduled — board meets 23 Oct 2026

BSE · Board Meeting·In 14 days

(opens in new tab)
Weighs against the SELL call (6)

MACD above its signal line — bullish momentum

Technicals · macd·9 Oct · today

Citi raises target for Dr Reddy's Laboratories stock to INR 1,450

NewsGoogle News·2 Oct · 6d ago

(opens in new tab)

Dr. Reddy's Laboratories stock gets a Citi upgrade to Buy

NewsGoogle News·1 Oct · 1w ago

(opens in new tab)

Dr. Reddy's Laboratories stock gets a Citi upgrade as margins face a test

NewsGoogle News·30 Sept · 1w ago

(opens in new tab)

Hikma signs exclusive licensing and distribution agreement with Dr. Reddy’s Laboratories for Nicotinell across MENA

NewsGoogle News·28 Sept · 1w ago

(opens in new tab)

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Dr. Reddy's Laboratories

All analyst calls on Dr. Reddy's Laboratories

More from Gaurav Sharma, Globe Capital Market

Every call and its outcome